BioXcel Therapeutics, Inc. Annual Interest Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
BioXcel Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2019 to 2023.
  • BioXcel Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $3.61M, a 7.13% increase year-over-year.
  • BioXcel Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $13.6M, a 17.1% increase year-over-year.
  • BioXcel Therapeutics, Inc. annual Interest Expense for 2023 was $13.3M, a 62.1% increase from 2022.
  • BioXcel Therapeutics, Inc. annual Interest Expense for 2022 was $8.21M, a 20433% increase from 2021.
  • BioXcel Therapeutics, Inc. annual Interest Expense for 2021 was $40K, a 48.1% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.3M +$5.1M +62.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 $8.21M +$8.17M +20433% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $40K +$13K +48.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $27K +$7K +35% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $20K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.